Fresenius is a global healthcare company headquartered in Bad Homburg vor der Höhe, Germany. In fiscal year 2024, Fresenius generated €21.5 billion in annual revenue with around 176,000 employees (excluding Fresenius Medical Care). As a healthcare company focused on therapy, Fresenius offers system-critical products and services for leading therapies for the care of critically and chronically ill patients. The company operates through its operating companies Fresenius Kabi (products for critically and chronically ill patients) and Fresenius Helios (Europe's leading private hospital operator), as well as its investment company Fresenius Medical Care (world's leading provider of dialysis products and services).
With more than 100 years of heritage, Fresenius is committed to its mission of saving and improving human lives with affordable, accessible, and innovative healthcare products and the highest quality in clinical care. Under the #FutureFresenius program, the company focuses on three therapy platforms: (Bio)Pharma including clinical nutrition, MedTech, and Care Provision. Fresenius serves approximately 4.5 million patients worldwide through its dialysis services alone and operates across Europe, the Americas, and other global markets, positioning itself for continuous growth in the evolving healthcare landscape.